Cardiovascular disease and risk factors in adults with hypopituitarism.
about
Aetiology, diagnosis, and management of hypopituitarism in adult lifeGrowth hormone and the heart.Hydrocortisone replacement dosage influences intraocular pressure in patients with primary and secondary hypocortisolism.The GH/IGF-1 Axis and Heart Failure.Hypopituitarism and atherosclerosis.Cardiovascular effects of growth hormone treatment: potential risks and benefits.Growth hormone (GH) replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapySafety and efficacy of growth hormone replacement therapy in adults.Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.Low-dose growth hormone is cardioprotective in uremia.Endocrine dysfunction following traumatic brain injury: a 5-year follow-up nationwide-based studyEffect of recombinant growth hormone replacement in a growth hormone deficient subject recovering from mild traumatic brain injury: A case report.Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency.Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.Hypopituitarism in the elderly: two case-reports with heterogeneous presentation.[Efficacy, safety and compliance of long-term growth hormone (GH) replacement therapy in adults with GH deficiency].Hypopituitarism 3 and 12 months after traumatic brain injury and subarachnoid haemorrhage.Neuroendocrine dysfunction in acute phase of moderate-to-severe traumatic brain injury: a prospective study.Role of pituitary dysfunction on cardiovascular risk in primary empty sella patients.Intra-operative diagnosis of hypopituitarism in a patient undergoing radical nephrectomy.Persisting effects on fasting glucose levels and insulin sensitivity after 6 months of discontinuation of a very low-dose GH therapy in adults with severe GH deficiency.Carotid atheromatic plaque is commonly associated with hypopituitary men.
P2860
Q24655732-CA664E0C-E8D2-4307-B6DD-4A52002A9BDFQ32026861-D6A66CCA-5B22-4BC6-AF30-146CD7E918FCQ32027154-2D0A14AB-5F3D-440B-A881-61FDB4F84FB6Q33654009-BFD20F28-EAA5-4941-9A89-8A1FD73B85A0Q34420018-76CD5799-3B4D-4338-A076-CEED743DA4E6Q35946594-E64952E7-466F-4330-B092-3550232350BDQ36088749-6FFCFE47-38C2-4923-B227-1EDA55787C17Q36299989-CDF804AC-D03F-42ED-8B2F-841BD5109284Q36516174-77F39DF7-7781-4C73-96DF-B16866496077Q36842446-1E4C39E3-5412-4D16-9260-645D72C5DF48Q37244177-4EC721B4-8051-4601-9669-D6C3F0195405Q39921282-60FD169B-7D07-4C5A-943F-48C286348B22Q42520402-302C0CBE-4BE3-4D0C-8CA1-523D26E7639FQ42635318-78CAC552-555D-4FBE-8E8A-DEBBCEEA7971Q42668786-940657FD-94D6-4922-837A-9122E98F1D4BQ43725582-ADB3CDBC-8B8D-47D8-9573-6570199228DDQ43967285-6EDF34B1-283F-44F3-AAC4-F6833958BFBFQ44753276-B1CB5FBE-E80B-4C01-8D18-C3A2BB743B28Q44856219-FD15B015-83E3-4B9E-A436-96CF9A49511BQ45050050-50C664E9-B7D2-4FB2-9EE3-D499CEADCF4AQ46118210-1FC9D9B9-8786-42B6-BCF0-D3E3152B0BE4Q46363159-FEC069C7-332F-4555-8B28-F7C75967CB04Q47892857-9DF73115-50A8-42B0-8148-48AC3EA0CB3AQ48049831-34E68E5A-EAB4-4F4C-92EC-E27F1CC2BAD4Q48265197-E863695C-37E6-43D6-9F73-8AB5F8C7E975Q48793332-88A4F96D-43B9-4309-B467-EB0C03E466A6Q51498823-1BCCFC6D-213F-417C-8FF4-309270AE6130Q51746490-4874B1DD-C8C5-4A3D-A74D-B8CE0A0E4624
P2860
Cardiovascular disease and risk factors in adults with hypopituitarism.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Cardiovascular disease and risk factors in adults with hypopituitarism.
@ast
Cardiovascular disease and risk factors in adults with hypopituitarism.
@en
type
label
Cardiovascular disease and risk factors in adults with hypopituitarism.
@ast
Cardiovascular disease and risk factors in adults with hypopituitarism.
@en
prefLabel
Cardiovascular disease and risk factors in adults with hypopituitarism.
@ast
Cardiovascular disease and risk factors in adults with hypopituitarism.
@en
P2860
P1476
Cardiovascular disease and risk factors in adults with hypopituitarism.
@en
P2093
Beshyah SA
Johnston DG
P2860
P356
10.1046/J.1365-2265.1999.00682.X
P577
1999-01-01T00:00:00Z